AusBiotech has outlined two key recommendations in its response to Investment NSW’s Innovation Blueprint consultation: invest in sector maturation, and foster a culture of...
Interview
New Stories
-
AusBiotech submits response on NSW Innovation Blueprint
April 18, 2024 - - AusBiotech -
Telix Pharmaceuticals records another quarter of strong revenue growth
April 18, 2024 - - Latest News -
Immutep appoints research institute to conduct first-in-human study of IMP761
April 18, 2024 - - Latest News -
MTPConnect says Australia poised to lead revolution in radiopharmaceuticals
April 18, 2024 - - Latest News -
Bioxyne receives commitments to raise funds to further product development
April 18, 2024 - - Latest News -
Telix's TLX101-CDx granted fast track designation by US FDA
April 16, 2024 - - Latest News -
AusBiotech welcomes the Medical Science Co-Investment Plan
April 16, 2024 - - AusBiotech